1886P Pembrolizumab and denosumab in clear cell renal cell carcinoma (ccRCC): A phase II trial (KeyPAD, ANZUP1601)

C. Gedye,C.A. Harris,M.R. Stockler, M. Morris, T. Ferguson, J.C.H. Goh,A. Martin,C.R. Underhill,D. Pook, L.E.M. Krieger,G. Kichenadasse, A.J. Joshi, S. Subramaniam, D.S. Zebic, A. Zhang,A.M. Joshua,G.C. Toner, P.A. Vasey,P. Prithviraj,I.D. Davis

Annals of Oncology(2023)

引用 0|浏览18
暂无评分
关键词
renal cell carcinoma,1886p pembrolizumab,denosumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要